You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for citric acid; gluconolactone; magnesium carbonate and what is the scope of patent protection?

Citric acid; gluconolactone; magnesium carbonate is the generic ingredient in one branded drug marketed by United Guardian and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE
Pharmacology for CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE

US Patents and Regulatory Information for CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
United Guardian RENACIDIN citric acid; gluconolactone; magnesium carbonate SOLUTION;IRRIGATION 019481-001 Oct 2, 1990 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Citric Acid, Gluconolactone, and Magnesium Carbonate

Last updated: February 15, 2026


What Are the Core Market Drivers for Citric Acid, Gluconolactone, and Magnesium Carbonate?

Citric Acid:

  • Used primarily as a food additive, preservative, and flavor enhancer.
  • Growing demand in beverage, bakery, and confectionery industries.
  • Rising interest in natural preservatives due to clean label movements.
  • Expanding applications in pharmaceuticals for mineral supplement formulations.

Gluconolactone:

  • Employed mainly in skincare products and cosmetics as a chelating agent and mild exfoliant.
  • Increasing consumer focus on gentle, natural skincare ingredients.
  • Rising use in food preservation and packaging as a pH buffer and preservative.
  • Growing popularity within the pharmaceutical industry as a stabilizer.

Magnesium Carbonate:

  • Applied as an antacid, laxative, and in sports medicine (chalk for gymnasts and climbers).
  • Expansion in dietary supplement markets for magnesium intake.
  • Increased use in agriculture as a soil pH regulator.
  • Growing demand in emerging markets for healthcare and sports products.

What Are the Major Market Trends and Growth Opportunities?

Substance Trends and Opportunities Key Markets Estimated Growth Rate (2022-2028)
Citric Acid Rising demand from beverage and food sectors; natural label shift North America, Asia Pacific 4-6% CAGR
Gluconolactone Increased use in skincare; demand for natural preservatives Europe, North America 5-7% CAGR
Magnesium Carbonate Growing supplement and sports markets; expanding applications in agriculture Asia Pacific, Latin America 4-6% CAGR

How Are Regulatory Policies Influencing the Market?

  • Food & Beverage Regulations:

    • The U.S. FDA and EFSA approve citric acid and magnesium carbonate as Generally Recognized as Safe (GRAS).
    • Stringent labeling requirements drive demand for natural substances with clear origins.
  • Cosmetics & Pharmaceuticals:

    • US FDA and EMA approve gluconolactone for skincare; overall strict safety assessments favor well-documented ingredients.
    • Regulatory agencies increasingly scrutinize chemical safety, favoring natural and mineral-based ingredients.
  • Environmental Policies:

    • Emphasis on sustainability influences manufacturing practices, favoring bio-based and eco-friendly processes.
    • Regulations in China, India, and Southeast Asia push for environmentally compliant production standards.

What Are the Key Market Players and Competitive Dynamics?

Company Market Share Focus Areas Notable Developments
Archer Daniels Midland (ADM) 15-20% Large-scale citric acid and magnesium carbonate production Expanded production facilities in Asia
Cargill 10-15% Food-grade acids and minerals Investment in sustainable sourcing
Jungbunzlauer 10-12% Specialty ingredients including gluconolactone New product development in skincare ingredients
Gadot Biochemical Industries 8-10% Citric acid and mineral salts Increasing exports to emerging markets

What Is the Financial Trajectory Based on Current Data?

  • Market Size (2022):

    • Citric Acid: Estimated at $3.2 billion (Global).
    • Gluconolactone (part of specialty acids): Estimated at ~$300 million, with rising demand.
    • Magnesium Carbonate: Approximate global value $400 million.
  • Growth Forecasts (2022-2028):

    • Citric Acid: CAGR of 4-6%; reaching ~$4.4 billion by 2028.
    • Gluconolactone: CAGR of 5-7%; market nearing $462 million by 2028.
    • Magnesium Carbonate: CAGR of 4-6%; approximating $530 million by 2028.
  • Profitability Trends:

    • Companies have driven margins through economies of scale, natural sourcing, and sustainable practices.
    • Price sensitivity persists, especially in commodity-sensitive sectors like food and pharmaceuticals.
  • Investment and Capital Expenditure:

    • Heavy capex in bio-based production methods and sustainable sourcing drives long-term returns.
    • Rising adoption of high-purity, pharmaceutical-grade products adds margins but requires regulatory compliance.

What Are the Risks Affecting Market Sustainability and Growth?

  • Price volatility driven by raw material costs (e.g., corn, molasses for citric acid; minerals for magnesium carbonate).
  • Environmental regulations may limit certain extraction or manufacturing processes.
  • Stringent safety and efficacy standards in the pharmaceutical and cosmetic sectors can delay product launches.
  • Supply chain disruptions impact raw material availability and cost.

Key Takeaways

  • The combined market for citric acid, gluconolactone, and magnesium carbonate is expanding, driven by food, cosmetics, and pharmaceuticals.
  • Growth in natural and clean-label products underpins demand, especially in North America and Asia Pacific.
  • Regulatory environment favors ingredients with well-documented safety profiles, encouraging sustainable manufacturing.
  • Major players are investing in capacity expansion and sustainable sourcing, maintaining competitive advantages.
  • Market growth remains subject to raw material costs, regulatory shifts, and global supply chain stability.

FAQs

1. What sectors are primarily influencing demand for these compounds?
Food and beverage, cosmetics, pharmaceuticals, and agriculture.

2. Which region exhibits the highest growth potential?
Asia Pacific, driven by expanding food manufacturing, cosmetics, and rural agriculture.

3. Are there sustainable or environmentally friendly alternatives impacting these markets?
Yes, plant-based bio-sources and green manufacturing processes are gaining traction.

4. How does regulation influence market entry for new products?
Stringent safety and environmental standards require comprehensive testing, increasing time-to-market and costs.

5. What is the future outlook for prices of these ingredients?
Prices tend to stabilize with increased manufacturing efficiency but remain sensitive to raw material costs and regulatory changes.


Sources
[1] Market research reports, industry publications, and regulatory agency data as of 2022-2023.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.